Hi Praetorian,
I hope all be good mate... But really the ann didnt came as a financially change, means they could not even qualify this info relevant for the point of view of market...probably because not even for the scientific point of view..
Im not "non sayer man... Im supportive of the MSB but i dislike absolutely this report.Yes..im 100% ignorant in medical area and no level to judge,but so many paragraphs stressing NON EFFICACY that obviously for a amateur like me sounds the REM-L didn't impressed so much...The worst is the smal area where they looks good than they say,,,.yes but need more works to see if its correct or npot... Obvious this gives zero confidence...
Not matches with ann that paint much rosie scenario.
CATO
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L for COPD Published in Respiratory Research
Ann: Remestemcel-L for COPD Published in Respiratory Research, page-54
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.3¢ |
Change
-0.018(1.82%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $900.6K | 949.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 22785 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 99045 | 50 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 48812 | 0.940 |
23 | 103057 | 0.935 |
18 | 164687 | 0.930 |
9 | 177764 | 0.925 |
14 | 499462 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 88360 | 43 |
0.950 | 99811 | 15 |
0.955 | 184910 | 16 |
0.960 | 49341 | 5 |
0.965 | 86295 | 6 |
Last trade - 14.55pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online